SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

05 Feb 2025 Evaluate
The Revenue for the quarter ended  December 2024 of Rs. 25159.00 millions grew by 6.10 % from Rs. 23713.00 millions.Net profit showed a marginal rise at Rs. 4706.00 millions for the quarter ended December 2024, as compared to corresponding quarter of last year.The company reported a degrowth in operating Profit to 7260.00 millions from 8059.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 25159.00 23713.00 6.10 92967.00 74863.00 24.18 108187.00 87316.00 23.90
Other Income 775.00 1068.00 -27.43 5654.00 8104.00 -30.23 11595.00 8219.00 41.08
PBIDT 7260.00 8059.00 -9.91 44744.00 32132.00 39.25 51435.00 30028.00 71.29
Interest 972.00 1039.00 -6.45 3085.00 2845.00 8.44 3907.00 2782.00 40.44
PBDT 6288.00 7020.00 -10.43 41659.00 29287.00 42.24 47442.00 25208.00 88.20
Depreciation 1316.00 1277.00 3.05 3959.00 3738.00 5.91 5044.00 4886.00 3.23
PBT 4972.00 5743.00 -13.43 37700.00 25549.00 47.56 42398.00 20322.00 108.63
TAX 266.00 1239.00 -78.53 8088.00 5186.00 55.96 7983.00 5030.00 58.71
Deferred Tax 508.00 51.00 896.08 528.00 -82.00 -743.90 -1360.00 412.00 -430.10
PAT 4706.00 4504.00 4.48 29612.00 20363.00 45.42 34415.00 15292.00 125.05
Equity 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59
PBIDTM(%) 28.86 33.99 -15.09 48.13 42.92 12.13 47.54 34.39 38.25

Zydus Lifesciences Share Price

939.20 3.20 (0.34%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×